Maria Rodriguez

14PUBLICATIONS
56CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 02, 2026
Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma.

|Jun 24, 2026
A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma.

|Aug 07, 2025
Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial.

Paolo Strati, Lei Feng, Jason R Westin

|Jun 15, 2025
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma.

Neha Akkad, Lei Feng, Jason R Westin

|Feb 05, 2025
Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas.

Dai Chihara, Raphael E Steiner, Ranjit Nair

|Jun 30, 2023
A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma.

Paolo Strati, Andrew Jallouk, Qing Deng

Pageof 3

Frequent Collaborators

13 joint publications

Jason Westin

12 joint publications

Sattva S Neelapu

7 joint publications

Sairah Ahmed

5 joint publications

Loretta Nastoupil